Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00021184
DRKS00021184
Completed
Not Applicable

Development of an senescence-associated system diagnostic kit for cancer and stroke - SASKit - SASKit

niversitätsmedizin Rostock0 sites150 target enrollmentMarch 27, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC25I63Malignant neoplasm of pancreasCerebral infarction

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C25
Sponsor
niversitätsmedizin Rostock
Enrollment
150
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 27, 2020
End Date
April 1, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsmedizin Rostock

Eligibility Criteria

Inclusion Criteria

  • •Newly diagnosed Adenocarcinoma of the pancreas in the advanced or metastatic stage, no previous system therapy
  • •Ischemic stroke of the supratentorial brain region before 3\-10 days (definitive cerebral infarction volume\> 10 ml on MRI)
  • •Control person who is neither brother nor sister and has an age difference of no more than 12 years.

Exclusion Criteria

  • •\- Age \<18 years
  • •\- previous or current medical tumor therapy
  • •\- other cancer within the past 2 years
  • •\- previous stroke with persistent deficit
  • •\- myocardial infarction within the past 2 years
  • •\- therapeutic anticoagulation, within the past 2 years up to the time of study enrollment, for a duration of more than 1 month
  • •The exclusion criteria are described in detail in our study protocol (Henze et al., BMJ open 10:e039560, 2020, PMID 33334830\)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A preliminary to investigate the effect of aging and exercise on muscle functioot applicable
JPRN-UMIN000032279Soiken Inc.6
Active, not recruiting
Phase 1
Glucophage trialKidney transplant patients 3 months after TX, witha stable kidney function, no signs of graft failure.No other conditions like heart failure, diabetes, ....MedDRA version: 14.1Level: LLTClassification code 10069030Term: Graft failureSystem Organ Class: 100000004863MedDRA version: 14.1Level: PTClassification code 10004782Term: Biopsy kidneySystem Organ Class: 10022891 - InvestigationsTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2012-003987-34-BEZ Leuven50
Recruiting
Not Applicable
Senescence and the early ageing phenotype after chemotherapy for testicular cancer: the SEA-CAT studyTesticular cancer10038364
NL-OMON52734niversitair Medisch Centrum Groningen192
Completed
Not Applicable
An exploratory study of noninvasive aging index of epidermis.
JPRN-UMIN000025013Kao Corporation30
Recruiting
Not Applicable
Establishment of immortalized cells involved in endometriosis and ovarian tumor.endometriosis, ovarian cyst
JPRN-UMIN000030867agoya University40